+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Blood Screening - Market Analysis, Trends, and Forecasts

  • ID: 4804718
  • Report
  • 346 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter
  • Biomérieux Sa
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ag
  • Grifols International Sa
  • MORE
Blood Screening market worldwide is projected to grow by US$1.8 Billion, driven by a compounded growth of 9.2%. Nucleic Acid Test (NAT), one of the segments analyzed and sized in this study, displays the potential to grow at over 9.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.7 Billion by the year 2025, Nucleic Acid Test (NAT) will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$60.3 Million to the region's size and clout in the next 5 to 6 years. Over US$52.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Nucleic Acid Test (NAT) will reach a market size of US$78.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.7% over the next couple of years and add approximately US$504.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Grifols International SA
  • Ortho Clinical Diagnostics, Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter
  • Biomérieux Sa
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ag
  • Grifols International Sa
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Blood Screening Market to Witness Moderate Growth

The Nucleic Acid Test (NAT) Segment to Register Highest Growth

Global Competitor Market Shares

Blood Screening Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Increase in Blood Donation Rates to Bode Well for Market Growth

Percentage of People Preferring to Donate Blood by Select Countries: 2018

Various Initiatives to Donate Blood Propel Market Growth

Rising Incidence of Infectious Diseases

Total Number of Disease Cases Reported in the US due to Infected Fleas, Ticks, and Mosquitoes: 2004-2016

Disease Response Towards Climate Change during the Recent Past

Opportunities and Challenges in Blood Screening

Innovations to Propel Market Growth

Various Measures for Ensuring Donated Blood Safety, a Key Driver for Market Growth

Introduction of Novel Products to Support Market Growth

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Blood Screening Market Share (in %) by Company: 2019 & 2025

CANADA

JAPAN

CHINA

EUROPE

Market Facts & Figures

European Blood Screening Market: Competitor Market Share Scenario (in %) for 2019 & 2025

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION

ABBOTT LABORATORIES

BECKMAN COULTER

BIO-RAD LABORATORIES

F. HOFFMANN-LA ROCHE AG

GRIFOLS INTERNATIONAL SA

ORTHO CLINICAL DIAGNOSTICS

SIEMENS HEALTHINEERS

THERMO FISHER SCIENTIFIC

BIOMÉRIEUX SA

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Beckman Coulter
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ag
  • Grifols International Sa
  • Ortho Clinical Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Biomérieux Sa
Note: Product cover images may vary from those shown
Adroll
adroll